• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明质酸合成抑制可使乙醇增强的肝星状细胞激活恢复正常。

Hyaluronan synthesis inhibition normalizes ethanol-enhanced hepatic stellate cell activation.

作者信息

Kotulkar Manasi, Robarts Dakota R, Lin-Rahardja Kristi, McQuillan Tara, Surgnier Jordan, Tague Sarah E, Czerwinski Maciej, Dennis Katie L, Pritchard Michele T

机构信息

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.

Kansas Intellectual and Developmental Disabilities Research Center, University of Kansas Medical Center, Kansas City, Kansas, USA.

出版信息

Alcohol Clin Exp Res (Hoboken). 2023 Aug;47(8):1544-1559. doi: 10.1111/acer.15127. Epub 2023 Jun 18.

DOI:10.1111/acer.15127
PMID:37332093
Abstract

BACKGROUND

Chronic ethanol overconsumption promotes alcohol-associated liver disease (ALD), characterized by hepatocyte injury, inflammation, hepatic stellate cell (HSC) activation, and fibrosis. Hyaluronan (HA) concentration is greater in livers and blood from advanced ALD patients than patients with advanced non-ALD. In the liver, HSCs are the major HA producers. The relationship between ethanol, HA, and HSC activation is incompletely understood. Thus, here, we tested the hypothesis that ethanol enhances HSC activation in a HA-dependent manner.

METHODS

Liver tissue microarrays (TMAs) containing steatotic livers from donors with or without a history of alcohol consumption were used to measure HA and collagen content. Mice were fed a moderate (2%, v/v) ethanol-containing diet or pair-fed control diet for 2 days, after which they were given a single carbon tetrachloride (CCl ) injection. To inhibit HA synthesis, we provided 4-methylumbelliferone (4MU) daily. We used LX2 cells, a human HSC cell line, to determine the impact ethanol had on LPS responses, with or without concurrent 4MU exposure.

RESULTS

CCl induced liver injury, but it did not differ between ethanol or control diet fed mice with or without 4MU treatment. Ethanol feeding enhanced CCl -induced hepatic HA content, which was paralleled by HA synthase (Has)2 transcript abundance; 4MU treatment normalized both. Consistently, HSC activation, assessed by measuring αSMA mRNA and protein, was induced by CCl exposure, enhanced by ethanol feeding, and normalized by 4MU. Hepatic transcripts, but not protein, for Ccl2 were enhanced by ethanol feeding and normalized by 4MU exposure. Finally, ethanol-exposed LX2 cells made more LPS-stimulated CCL2 mRNA and protein than cells not exposed to ethanol; 4MU prevented this.

CONCLUSION

These data show that ethanol augments HSC activation through HA synthesis and enhances hepatic profibrogenic features. Therefore, targeting HSC HA production could potentially attenuate liver disease in ALD patients.

摘要

背景

长期过量摄入乙醇会引发酒精性肝病(ALD),其特征为肝细胞损伤、炎症、肝星状细胞(HSC)激活及纤维化。晚期ALD患者肝脏和血液中的透明质酸(HA)浓度高于晚期非ALD患者。在肝脏中,HSCs是主要的HA产生细胞。乙醇、HA与HSC激活之间的关系尚未完全明确。因此,在此我们检验了乙醇以HA依赖的方式增强HSC激活的假说。

方法

使用包含有或无饮酒史供体的脂肪变性肝脏的肝组织微阵列(TMA)来测量HA和胶原蛋白含量。给小鼠喂食含适量(2%,v/v)乙醇的饮食或配对喂食对照饮食2天,之后单次注射四氯化碳(CCl)。为抑制HA合成,我们每日给予4-甲基伞形酮(4MU)。我们使用人HSC细胞系LX2细胞来确定乙醇对LPS反应的影响,同时或不同时给予4MU。

结果

CCl诱导肝损伤,但在给予或未给予4MU治疗的情况下,喂食乙醇或对照饮食的小鼠之间无差异。喂食乙醇会增加CCl诱导的肝脏HA含量,同时HA合酶(Has)2转录本丰度也相应增加;4MU治疗可使两者恢复正常。同样,通过测量αSMA mRNA和蛋白评估的HSC激活由CCl暴露诱导,喂食乙醇会增强,而4MU可使其恢复正常。乙醇喂食会增加肝脏中Ccl2的转录本,但不增加蛋白,4MU暴露可使其恢复正常。最后,暴露于乙醇的LX2细胞比未暴露于乙醇的细胞产生更多LPS刺激的CCL2 mRNA和蛋白;4MU可阻止这种情况。

结论

这些数据表明乙醇通过HA合成增强HSC激活并增强肝脏促纤维化特征。因此,针对HSC HA产生可能会减轻ALD患者的肝病。

相似文献

1
Hyaluronan synthesis inhibition normalizes ethanol-enhanced hepatic stellate cell activation.透明质酸合成抑制可使乙醇增强的肝星状细胞激活恢复正常。
Alcohol Clin Exp Res (Hoboken). 2023 Aug;47(8):1544-1559. doi: 10.1111/acer.15127. Epub 2023 Jun 18.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Perfluorooctane sulfonate (PFOS) exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model.在小鼠慢性暴饮乙醇喂养模型中全氟辛烷磺酸(PFOS)暴露与酒精性肝病严重程度的关系
Toxicol Sci. 2025 May 10. doi: 10.1093/toxsci/kfaf066.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease.人肝星状细胞的多模态分析确定了代谢功能障碍相关脂肪性肝病的新治疗靶点。
J Hepatol. 2025 May;82(5):882-897. doi: 10.1016/j.jhep.2024.10.044. Epub 2024 Nov 8.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Targeting Hepatic Stellate Cell PD-L1 Alters Liver Inflammation and Fibrosis in CCl Liver Injury Mouse Model.靶向肝星状细胞程序性死亡受体配体1可改变四氯化碳诱导的肝损伤小鼠模型中的肝脏炎症和纤维化。
Cell Mol Gastroenterol Hepatol. 2025 Jul 16:101587. doi: 10.1016/j.jcmgh.2025.101587.
8
CD73 Blockade Alleviated Hepatic Fibrosis via Inhibiting Hepatic Stellate Cells Proliferation and Activation.CD73 阻断通过抑制肝星状细胞增殖和活化减轻肝纤维化。
Curr Mol Pharmacol. 2024;17(1):e220323214863. doi: 10.2174/1874467216666230322113039.
9
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
The potential of 4-Methylumbelliferone to be repurposed for treating liver fibrosis.4-甲基伞形酮用于治疗肝纤维化的潜在用途。
bioRxiv. 2025 May 23:2025.05.19.654778. doi: 10.1101/2025.05.19.654778.
2
Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells.肝星状细胞将脂肪性肝病与肝细胞癌联系起来。
J Natl Cancer Cent. 2024 Jan 18;4(1):25-35. doi: 10.1016/j.jncc.2024.01.002. eCollection 2024 Mar.

本文引用的文献

1
Pathogenesis of Alcohol-Associated Liver Disease.酒精性肝病的发病机制
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1492-1513. doi: 10.1016/j.jceh.2022.05.004. Epub 2022 May 31.
2
Sex Differences in Alcohol Consumption and Alcohol-Associated Liver Disease.性别差异与饮酒和酒精性肝病。
Mayo Clin Proc. 2021 Apr;96(4):1006-1016. doi: 10.1016/j.mayocp.2020.08.020. Epub 2021 Mar 10.
3
Molecular and cellular mechanisms of liver fibrosis and its regression.肝纤维化及其逆转的分子和细胞机制。
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):151-166. doi: 10.1038/s41575-020-00372-7. Epub 2020 Oct 30.
4
Tissue-specific Fixation Methods Are Required for Optimal In Situ Visualization of Hyaluronan in the Ovary, Kidney, and Liver.组织特异性固定方法对于在卵巢、肾脏和肝脏中进行透明质酸的原位可视化观察是必需的。
J Histochem Cytochem. 2020 Jan;68(1):75-91. doi: 10.1369/0022155419884879. Epub 2019 Nov 12.
5
Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.透明质酸合酶 2 介导的透明质酸生成介导 Notch1 激活和肝纤维化。
Sci Transl Med. 2019 Jun 12;11(496). doi: 10.1126/scitranslmed.aat9284.
6
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema.腺苷和透明质酸促进合并肺纤维化和肺气肿的肺纤维化和肺动脉高压。
Dis Model Mech. 2019 May 15;12(5):dmm038711. doi: 10.1242/dmm.038711.
7
4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition.4-甲基伞形酮基-β-D-葡糖苷酸抑制透明质酸的合成。
J Biol Chem. 2019 May 10;294(19):7864-7877. doi: 10.1074/jbc.RA118.006166. Epub 2019 Mar 26.
8
Alcoholic liver disease: Utility of animal models.酒精性肝病:动物模型的应用。
World J Gastroenterol. 2018 Dec 7;24(45):5063-5075. doi: 10.3748/wjg.v24.i45.5063.
9
Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration.酒精性肝病的啮齿动物模型: binge 乙醇给药的作用。
Biomolecules. 2018 Jan 13;8(1):3. doi: 10.3390/biom8010003.
10
Histopathological evaluation of liver fibrosis and cirrhosis regression.肝纤维化和肝硬化逆转的组织病理学评估。
Clin Mol Hepatol. 2017 Dec;23(4):302-307. doi: 10.3350/cmh.2017.0078. Epub 2017 Dec 20.